Hepatitis C Virus is considered to be the principal etiologic agent responsible for 90-95% of the cases of posttransfusion non-A and non-B hepatitis. Approximately 170 million people worldwide are chronically infected with HCV. But only 20% patents can be diagnosed. As a blood-borne virus, HCV can be transmitted by blood and blood products. So early diagnosis is very important. HCV PCR Fluorescence Quantitative Diagnostic kit combines the technologies of nucleic acid amplification and probe to detect HCV RNA.

HCV RNA is reverse transcribed and a specific fragment is amplified with specific primers in a one-step RT-PCR reaction. The products are detected by using a specific Taqman-MGB Probe.

• High sensitivity: It can detect 500 copies/ml stably.
  
• High Specificity: Apply to a variety of different HCV subtypes detection, detection of B hepatitis virus, human immunodeficiency virus (HIV), hepatitis G virus, hepatitis E virus were maintained good negative results.
  
• Pollution prevention: Finish the RT-PCR only one step, doesn’t need reverse transcription and PCR treatment. Complete closed tube amplification and detection, avoiding false positive results.
  
• Simplicity of operation: It only take 2 hours to finish all PCR process.